[Familial defective apolipoprotein B100: FDB].
Nohara
A
A
Second Department of Internal Medicine, School of Medicine, Kanazawa University.
Mabuchi
H
H
D000012:Abetalipoproteinemia / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy; D053299:Apolipoprotein B-100; D001055:Apolipoproteins B / Q000235:genetics / Q000378:metabolism; D001781:Blood Component Removal; D003937:Diagnosis, Differential; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D009154:Mutation; D011379:Prognosis; D011973:Receptors, LDL / Q000378:metabolism
D053299:Apolipoprotein B-100; D001055:Apolipoproteins B; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011973:Receptors, LDL